Company Overview

Novo Nordisk is a focused healthcare company. With the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems, Novo Nordisk is the world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as coagulation disorders, growth disorders and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.

Company Information

Additional Details

Legal Name: Novo Nordisk Canada Inc.

Number of Employees: 100

Contacts

Services

• Biotechnology

Products

• Flexpen

  A prefilled insulin pen

• Gluconorm

  Repaglinide Tablet

• Induo

  Combined insulin doser and blood glucose monitor

• Innovo

  Insulin doser with built in memory

• Niastase

  Niastase is recombinant factor VIIa used in the treatment of hemophilia.

• Novofine Needles

  Needles for Novo Nordisk insulin injection devices

• Novolin
• Novolin Pen

  Novolin Pen is a device for the injection of insulin from prefilled cartridges allowing patients greater convenience and improved quality of life.

• Novopen Junior

  Pen with half-unit dose increments to fine-tune small doses for children.

• Novorapid

  A clear solution containing a modified form of human insulin, is also known as a 'rapid-acting insulin analogue'.

• Vagifem

  Used for Local Oestrogen treatment

NAICS Categories

• 325410 Pharmaceutical and Medicine Manufacturing

Additional Information